2-bromoethylamine has been researched along with Cirrhosis in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arruda, JA; Desai, SS; Dunea, G; Garber, SL; Mirochnik, Y | 1 |
Arruda, JA; Dunea, G; Garber, SL; Mirochnik, Y | 1 |
Arruda, JA; Au, J; Brecklin, C; Dunea, G; Garber, SL; Mo, W; Pegoraro, AA; Singh, AK; Song, RH | 1 |
Kagan, HM | 1 |
Arruda, JA; Brecklin, CS; Dunea, G; Garber, SL; Grove, BH; Mirochnik, Y; Singh, AK; Slobodskoy, L; Unemori, EN | 1 |
1 review(s) available for 2-bromoethylamine and Cirrhosis
Article | Year |
---|---|
Intra- and extracellular enzymes of collagen biosynthesis as biological and chemical targets in the control of fibrosis.
Topics: Aminopropionitrile; Animals; Benzylamines; Cells, Cultured; Collagen; Enzyme Inhibitors; Esters; Ethylamines; Fibrosis; Humans; Lactones; Procollagen-Proline Dioxygenase; Protein-Lysine 6-Oxidase | 2000 |
4 other study(ies) available for 2-bromoethylamine and Cirrhosis
Article | Year |
---|---|
Angiotensin-converting enzyme inhibition reduces the effect of bromoethylamine-induced papillary necrosis and renal fibrosis.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Creatinine; Enalapril; Ethylamines; Fibrosis; Glomerular Filtration Rate; Kidney; Kidney Diseases; Kidney Papillary Necrosis; Male; Rats; Rats, Sprague-Dawley | 1998 |
Evolution of experimentally induced papillary necrosis to focal segmental glomerulosclerosis and nephrotic proteinuria.
Topics: Animals; Creatinine; Ethylamines; Fibrosis; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Kidney Medulla; Kidney Papillary Necrosis; Male; Proteinuria; Rats; Rats, Sprague-Dawley | 1999 |
Changes in collagenases and TGF-beta precede structural alterations in a model of chronic renal fibrosis.
Topics: Animals; Chronic Disease; Collagenases; Ethylamines; Fibrosis; Gelatinases; Kidney; Kidney Papillary Necrosis; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tissue Distribution; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Transforming Growth Factor beta | 1999 |
Relaxin decreases renal interstitial fibrosis and slows progression of renal disease.
Topics: Animals; Creatinine; Disease Progression; Ethylamines; Fibrosis; Kidney; Kidney Cortex; Kidney Diseases; Kidney Medulla; Kidney Tubules; Male; Rats; Rats, Sprague-Dawley; Relaxin; Transforming Growth Factor beta | 2001 |